The state of Kansas will receive over $45 million total from two pharmaceutical companies as the state’s fight against opioid abuse continues. Outgoing Attorney General Derek Schmidt says Teva has agreed to pay nearly $29 million. Part of that particular settlement involves Teva agreeing to stop promoting or lobbying for opioid products. Teva also has to monitor and report “off-label” use of fentanyl-based products, share clinical data through and disclose records to a third-party entity and pay for an independent agency to ensure compliance.
Source: KVOE Emporia Radio
